Ligand Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /66
Ligand Pharmaceuticalsの総株主資本は$841.2M 、総負債は$0.0で、負債比率は0%となります。総資産と総負債はそれぞれ$954.9Mと$113.7Mです。 Ligand Pharmaceuticalsの EBIT は$18.0Mで、利息カバレッジ比率-3.2です。現金および短期投資は$219.6Mです。
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | -3.2x |
| 現金 | US$219.64m |
| エクイティ | US$841.18m |
| 負債合計 | US$113.69m |
| 総資産 | US$954.87m |
財務の健全性に関する最新情報
We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
May 29
These 4 Measures Indicate That Ligand Pharmaceuticals (NASDAQ:LGND) Is Using Debt Reasonably Well
Jan 26We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
Oct 21Here's Why Ligand Pharmaceuticals (NASDAQ:LGND) Can Manage Its Debt Responsibly
Jun 27Recent updates
Market Participants Recognise Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Earnings
Oct 31Ligand Pharmaceuticals: Solid Performer Performing Solidly
Jul 29Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 18Should You Be Adding Ligand Pharmaceuticals (NASDAQ:LGND) To Your Watchlist Today?
Jun 29Subdued Growth No Barrier To Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) With Shares Advancing 27%
May 23Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio
Apr 30Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Not Flying Under The Radar
Dec 19Is Now The Time To Put Ligand Pharmaceuticals (NASDAQ:LGND) On Your Watchlist?
Jun 14We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
May 29Are Investors Undervaluing Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) By 45%?
May 07These 4 Measures Indicate That Ligand Pharmaceuticals (NASDAQ:LGND) Is Using Debt Reasonably Well
Jan 26We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
Oct 21Ligand Pharmaceuticals: Struggling Along
Sep 25Growth Investors: Industry Analysts Just Upgraded Their Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Revenue Forecasts By 11%
Aug 11Here's Why Ligand Pharmaceuticals (NASDAQ:LGND) Can Manage Its Debt Responsibly
Jun 27Ligand Pharmaceuticals: Moving Parts Keep Moving
Mar 29財務状況分析
短期負債: LGNDの 短期資産 ( $309.4M ) が 短期負債 ( $24.8M ) を超えています。
長期負債: LGNDの短期資産 ( $309.4M ) が 長期負債 ( $88.9M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: LGNDは負債がありません。
負債の削減: LGND負債比率が74.2%であった 5 年前と比べて負債がありません。
債務返済能力: LGNDには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: LGNDには負債がないため、利息支払い の負担は問題になりません。